Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0367 USD | +0.94% | +9.55% | -8.25% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 26.53 | 21.83 | 21.64 | 47.23 | 16.73 | 20.79 |
Enterprise Value (EV) 1 | 31.01 | 29.51 | 29.67 | 55.94 | 22.47 | 26.45 |
P/E ratio | -31.3 x | -14.3 x | 9.8 x | -49.8 x | 54.8 x | -23.8 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 2.56 x | 2.44 x | 2.31 x | 4.89 x | 1.5 x | 1.69 x |
EV / Revenue | 2.99 x | 3.3 x | 3.17 x | 5.79 x | 2.01 x | 2.16 x |
EV / EBITDA | 4,307 x | -117 x | -401 x | 146 x | -28.9 x | -70.9 x |
EV / FCF | 30 x | -11.3 x | 41.5 x | -96.9 x | -14.3 x | 47.1 x |
FCF Yield | 3.33% | -8.86% | 2.41% | -1.03% | -7% | 2.12% |
Price to Book | -16.5 x | -9.99 x | 37.7 x | 17.3 x | 3.85 x | 5.15 x |
Nbr of stocks (in thousands) | 413,168 | 419,842 | 424,344 | 502,468 | 514,890 | 519,788 |
Reference price 2 | 0.0642 | 0.0520 | 0.0510 | 0.0940 | 0.0325 | 0.0400 |
Announcement Date | 3/19/19 | 3/30/20 | 3/30/21 | 3/31/22 | 4/6/23 | 3/29/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 10.37 | 8.955 | 9.365 | 9.662 | 11.18 | 12.27 |
EBITDA 1 | 0.007199 | -0.2517 | -0.074 | 0.3837 | -0.7784 | -0.3731 |
EBIT 1 | -0.2901 | -0.5583 | -0.4157 | -0.2408 | -1.203 | -0.7763 |
Operating Margin | -2.8% | -6.23% | -4.44% | -2.49% | -10.76% | -6.33% |
Earnings before Tax (EBT) 1 | -0.6639 | -1.201 | 2.443 | -0.789 | 0.3032 | -0.869 |
Net income 1 | -0.8446 | -1.523 | 2.203 | -0.9023 | 0.3032 | -0.869 |
Net margin | -8.15% | -17.01% | 23.52% | -9.34% | 2.71% | -7.08% |
EPS 2 | -0.002054 | -0.003642 | 0.005206 | -0.001888 | 0.000593 | -0.001678 |
Free Cash Flow 1 | 1.033 | -2.615 | 0.7145 | -0.5772 | -1.573 | 0.5613 |
FCF margin | 9.96% | -29.21% | 7.63% | -5.97% | -14.07% | 4.58% |
FCF Conversion (EBITDA) | 14,348.6% | - | - | - | - | - |
FCF Conversion (Net income) | - | - | 32.44% | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/19/19 | 3/30/20 | 3/30/21 | 3/31/22 | 4/6/23 | 3/29/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 4.48 | 7.68 | 8.03 | 8.71 | 5.74 | 5.66 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 622.8 x | -30.52 x | -108.5 x | 22.69 x | -7.37 x | -15.16 x |
Free Cash Flow 1 | 1.03 | -2.62 | 0.71 | -0.58 | -1.57 | 0.56 |
ROE (net income / shareholders' equity) | -265% | -5,721% | 176% | -28.1% | 8.57% | -20.7% |
ROA (Net income/ Total Assets) | -1.45% | -2.47% | -1.61% | -0.9% | -4.62% | -2.93% |
Assets 1 | 58.23 | 61.64 | -137.2 | 100.2 | -6.569 | 29.69 |
Book Value Per Share 2 | -0 | -0.0100 | 0 | 0.0100 | 0.0100 | 0.0100 |
Cash Flow per Share 2 | 0 | 0 | 0 | 0 | 0 | 0.0100 |
Capex 1 | 0.09 | 0.21 | 0.01 | 0.21 | 0.12 | 0.15 |
Capex / Sales | 0.83% | 2.32% | 0.08% | 2.13% | 1.07% | 1.22% |
Announcement Date | 3/19/19 | 3/30/20 | 3/30/21 | 3/31/22 | 4/6/23 | 3/29/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-8.25% | 19.19M | |
+10.52% | 33.8B | |
+24.67% | 8.62B | |
+14.64% | 8.22B | |
+27.75% | 5.8B | |
-6.30% | 4.04B | |
+17.08% | 3.8B | |
+12.21% | 3.71B | |
+24.57% | 3.69B | |
-6.79% | 2.81B |
- Stock Market
- Equities
- INIS Stock
- Financials International Isotopes Inc.